| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
29,913 |
25,395 |
$10.80M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,989 |
17,193 |
$4.74M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
43,613 |
41,128 |
$3.14M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,933 |
15,731 |
$2.99M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
30,556 |
28,407 |
$2.59M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,094 |
5,703 |
$839K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
30,102 |
28,291 |
$652K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
664 |
631 |
$446K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
244 |
218 |
$197K |
| 36415 |
Collection of venous blood by venipuncture |
35,500 |
32,249 |
$192K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,447 |
1,414 |
$183K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,726 |
6,163 |
$147K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,785 |
2,523 |
$145K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,105 |
1,953 |
$139K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,139 |
27,642 |
$105K |
| 71045 |
Radiologic examination, chest; single view |
2,212 |
1,916 |
$84K |
| 99233 |
Prolong inpt eval add15 m |
1,279 |
318 |
$81K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
32 |
28 |
$81K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,241 |
1,146 |
$67K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,115 |
3,966 |
$67K |
| 80053 |
Comprehensive metabolic panel |
10,832 |
10,204 |
$64K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
444 |
436 |
$58K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,223 |
302 |
$54K |
| 71046 |
Radiologic examination, chest; 2 views |
1,151 |
1,092 |
$42K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
61 |
53 |
$37K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
337 |
327 |
$36K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
289 |
144 |
$36K |
| 99223 |
Prolong inpt eval add15 m |
282 |
197 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,168 |
6,693 |
$28K |
| 70450 |
Computed tomography, head or brain; without contrast material |
533 |
480 |
$24K |
| 87631 |
|
317 |
305 |
$23K |
| 93296 |
|
738 |
721 |
$23K |
| 70310 |
|
400 |
378 |
$21K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
254 |
246 |
$20K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
263 |
256 |
$18K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
263 |
245 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,171 |
2,141 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
222 |
216 |
$14K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
51 |
51 |
$14K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
44 |
44 |
$12K |
| 99222 |
Initial hospital care, per day, moderate complexity |
170 |
133 |
$12K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
95 |
46 |
$12K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
40 |
40 |
$11K |
| 94060 |
|
90 |
78 |
$9K |
| 80061 |
Lipid panel |
792 |
774 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
404 |
386 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
122 |
96 |
$7K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
136 |
126 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
189 |
189 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
189 |
189 |
$7K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
14 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
140 |
136 |
$6K |
| 81001 |
|
2,808 |
2,680 |
$6K |
| 84484 |
|
600 |
540 |
$6K |
| 94010 |
|
107 |
95 |
$6K |
| 31575 |
|
39 |
39 |
$6K |
| 99220 |
|
47 |
47 |
$5K |
| 85610 |
|
1,304 |
699 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
90 |
87 |
$5K |
| 87070 |
|
423 |
417 |
$4K |
| 88142 |
|
233 |
233 |
$4K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
208 |
93 |
$4K |
| 80306 |
|
104 |
92 |
$4K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
16 |
15 |
$3K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
15 |
15 |
$3K |
| 76801 |
|
28 |
28 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
242 |
230 |
$3K |
| 83690 |
|
540 |
498 |
$2K |
| 88307 |
|
24 |
24 |
$2K |
| 73630 |
|
136 |
109 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
49 |
47 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
43 |
41 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
13 |
$2K |
| 73610 |
|
57 |
52 |
$2K |
| 00811 |
|
14 |
13 |
$2K |
| 99221 |
|
30 |
27 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,460 |
2,232 |
$2K |
| 00731 |
|
14 |
12 |
$1K |
| 99217 |
|
30 |
27 |
$1K |
| 99219 |
|
17 |
17 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32 |
27 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
25 |
$1K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
39 |
39 |
$1K |
| 94726 |
|
90 |
81 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
44 |
41 |
$1K |
| 11721 |
|
44 |
43 |
$1K |
| 85027 |
|
300 |
283 |
$1K |
| 99215 |
Prolong outpt/office vis |
13 |
12 |
$1K |
| 83605 |
|
202 |
183 |
$1K |
| 73130 |
|
36 |
26 |
$1K |
| 81003 |
|
374 |
358 |
$1K |
| 95249 |
|
30 |
30 |
$1K |
| 86780 |
|
77 |
76 |
$1K |
| 86769 |
|
27 |
26 |
$998.32 |
| 81025 |
|
226 |
215 |
$965.72 |
| 84439 |
|
75 |
73 |
$960.71 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$942.75 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
14 |
14 |
$661.79 |
| 93970 |
|
29 |
27 |
$659.38 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
14 |
14 |
$651.31 |
| 82077 |
|
33 |
28 |
$636.48 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
24 |
24 |
$619.92 |
| 86850 |
|
66 |
63 |
$605.96 |
| 93971 |
|
43 |
42 |
$553.38 |
| 86140 |
|
162 |
150 |
$512.65 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
30 |
28 |
$499.47 |
| 80179 |
|
17 |
13 |
$488.40 |
| 80143 |
|
17 |
13 |
$488.40 |
| 74018 |
|
93 |
68 |
$487.09 |
| 99152 |
|
62 |
58 |
$467.84 |
| 99406 |
|
26 |
25 |
$460.95 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,488 |
1,778 |
$453.76 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14 |
14 |
$449.18 |
| 0764T |
|
14 |
12 |
$449.10 |
| 0002A |
|
33 |
32 |
$431.66 |
| 95886 |
|
212 |
209 |
$402.00 |
| 82728 |
|
26 |
25 |
$390.01 |
| 88141 |
|
13 |
13 |
$356.07 |
| 73564 |
|
50 |
42 |
$321.25 |
| 94729 |
|
96 |
85 |
$313.92 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$270.90 |
| 88300 |
|
13 |
13 |
$270.72 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,031 |
588 |
$253.12 |
| 87340 |
|
26 |
26 |
$252.29 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
14 |
$247.56 |
| 86787 |
|
14 |
14 |
$246.72 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$241.10 |
| 73030 |
|
48 |
42 |
$239.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
16 |
16 |
$219.22 |
| 82248 |
|
126 |
118 |
$208.91 |
| 88304 |
|
15 |
14 |
$198.78 |
| 82607 |
|
12 |
12 |
$186.87 |
| 87077 |
|
14 |
14 |
$185.14 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,419 |
1,365 |
$181.73 |
| 86762 |
|
14 |
14 |
$177.87 |
| 0001A |
|
21 |
20 |
$177.10 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
502 |
461 |
$177.04 |
| 87660 |
|
12 |
12 |
$160.60 |
| 87510 |
|
12 |
12 |
$154.24 |
| 87480 |
|
12 |
12 |
$152.64 |
| 82043 |
|
25 |
25 |
$134.35 |
| 87186 |
|
14 |
14 |
$126.58 |
| 86900 |
|
39 |
39 |
$118.89 |
| 86901 |
|
39 |
39 |
$118.89 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,384 |
1,113 |
$105.85 |
| 84450 |
|
40 |
40 |
$97.44 |
| 82570 |
|
14 |
14 |
$97.15 |
| J2704 |
Injection, propofol, 10 mg |
1,265 |
590 |
$82.28 |
| 92567 |
|
13 |
13 |
$81.70 |
| 85652 |
|
117 |
110 |
$73.96 |
| 73110 |
|
16 |
12 |
$72.77 |
| 82565 |
|
31 |
27 |
$62.00 |
| A9270 |
Non-covered item or service |
55 |
40 |
$58.75 |
| 84460 |
|
25 |
25 |
$57.87 |
| 83735 |
|
96 |
90 |
$44.88 |
| 86200 |
|
12 |
12 |
$44.07 |
| 86039 |
|
42 |
37 |
$12.33 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
16 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
78 |
63 |
$0.00 |
| 91300 |
|
54 |
49 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
42 |
39 |
$0.00 |
| 92504 |
|
13 |
13 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
13 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
51 |
24 |
$0.00 |
| 84702 |
|
14 |
13 |
$0.00 |
| 90691 |
|
16 |
16 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
64 |
61 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
13 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
211 |
185 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
56 |
55 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
178 |
112 |
$0.00 |
| 85018 |
|
12 |
12 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
28 |
24 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
24 |
24 |
$0.00 |
| J3490 |
Unclassified drugs |
18 |
12 |
$0.00 |